Europe CT Market Size (2024 - 2029)

The Europe CT market is projected to experience growth over the forecast period, driven by factors such as an increasing geriatric population, a rise in chronic disease diagnoses, and advancements in medical imaging technology. The market's expansion is further supported by the heightened demand for CT scans, which was notably influenced by their role in diagnosing and managing COVID-19 patients. Despite these growth drivers, challenges such as high costs and stringent regulations may impede market progress.

Market Size of Europe CT Industry

Europe CT Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 2.19 Billion
Market Size (2029) USD 2.94 Billion
CAGR (2024 - 2029) 6.16 %

Major Players

Europe CT Market Major Players

*Disclaimer: Major Players sorted in no particular order

Europe CT Market Analysis

The Europe CT Market size is estimated at USD 2.19 billion in 2024, and is expected to reach USD 2.94 billion by 2029, growing at a CAGR of 6.16% during the forecast period (2024-2029).

COVID-19 significantly impacted the growth of the market over the forecast period. As per an NCBI article published in June 2021, CT examination played an important auxiliary role in the diagnosis and subsequent management of COVID-19 patients in Europe. CT scans can reduce the chance of false-negative results in the RT-PCR assay. These findings led to increased demand for CT scans in Europe during COVID-19, thereby having a significant impact on the growth of the market. Furthermore, the demand for CT in Europe is expected to remain stable due to the increased emphasis on chronic disease diagnosis during the post-pandemic period, contributing to the market's growth over the forecast period.

The significant factors for the European computed tomography (CT) market include the rising geriatric population and increase in incidences of chronic diseases, an increase in the shift of medical care toward image-guided interventions, and technological advancements in the region. The burden of chronic diseases is on the rise across Europe, and medical imaging procedures play a crucial role in the accurate diagnosis of these diseases. Chronic diseases, such as heart disease, stroke, cancer, diabetes, obesity, and arthritis, are among the most common, expensive, and preventable of all health problems. As per the data provided in the British Heart Foundation report in August 2022, 6.4 million people are living with a heart or circulatory disease, and 12 infants are diagnosed with a heart defect. Moreover, according to the data published by the World Data Atlas, in 2021, the population aged 65 years and older was 23.6% in Italy, and this target population aged 65 years and older in Italy increased from 11.5 % in 1972 to 23.6 % in 2021, which is growing at an average annual rate of 1.47%. This increase in the aging population in the country is anticipated to suffer from chronic diseases requiring an increased rate of diagnosis, which is anticipated to drive the studied market growth over the forecast period.

Additionally, the rising product launches by various key market players are expected to contribute to the growth of the market. For instance, in November 2021, Siemens Healthcare launched a photon-counting CT scanner called Naeotom Alpha, and this system is cleared for clinical use in Europe.

However, expensive procedures and instruments and a stringent regulatory framework are expected to restrain the growth of the market.

Europe CT Industry Segmentation

As per the scope of the report, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images, or scans, of areas inside the body. Also called computerized axial tomography (CAT) scanning, it is primarily used in cancer diagnosis. The Europe CT market is divided into four regions: Germany, the United Kingdom, France, Spain, Italy, and the rest of Europe. The report offers the value (in USD million) for the above segments.

By Type
Low Slice
Medium Slice
High Slice
By Application
Oncology
Neurology
Cardiovascular
Musculoskeletal
Other Applications
By End User
Hospitals
Diagnostic Centers
Other End-Users
Geography
United Kingdom
Germany
France
Spain
Italy
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe CT Market Size Summary

The European CT market is poised for significant growth over the forecast period, driven by several key factors. The rising geriatric population and the increasing prevalence of chronic diseases are central to this expansion, as medical imaging becomes crucial for accurate diagnosis and management. The shift towards image-guided interventions and technological advancements further bolster market growth. The COVID-19 pandemic underscored the importance of CT scans in diagnosing and managing the virus, leading to a surge in demand. This trend is expected to continue as the focus on chronic disease diagnosis remains strong in the post-pandemic landscape. Despite challenges such as high costs and stringent regulations, the market is supported by ongoing product innovations and strategic initiatives by major players like GE Healthcare, Siemens AG, and Koninklijke Philips NV.

Germany is anticipated to lead the European CT market, fueled by a high incidence of chronic conditions and a supportive regulatory environment. The country's aging population and the increasing demand for effective diagnostic solutions contribute to its market dominance. The competitive landscape is characterized by the presence of several key players, with ongoing advancements in imaging technologies enhancing market offerings. The introduction of new products, such as Siemens Healthcare's photon-counting CT scanner and GE Healthcare's positron emission tomography/CT platform, highlights the dynamic nature of the market. As the burden of chronic diseases and the need for early diagnosis continue to rise, the European CT market is expected to experience robust growth, with Germany at the forefront.

Explore More

Europe CT Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Incidence of Cancer & Chronic Diseases

      2. 1.2.2 Advancement in Technology

    3. 1.3 Market Restraints

      1. 1.3.1 Expensive Procedures and Instruments

      2. 1.3.2 Stringent Regulatory Framework

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Value - in USD Million)

    1. 2.1 By Type

      1. 2.1.1 Low Slice

      2. 2.1.2 Medium Slice

      3. 2.1.3 High Slice

    2. 2.2 By Application

      1. 2.2.1 Oncology

      2. 2.2.2 Neurology

      3. 2.2.3 Cardiovascular

      4. 2.2.4 Musculoskeletal

      5. 2.2.5 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Diagnostic Centers

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 United Kingdom

      2. 2.4.2 Germany

      3. 2.4.3 France

      4. 2.4.4 Spain

      5. 2.4.5 Italy

      6. 2.4.6 Rest of Europe

Europe CT Market Size FAQs

The Europe CT Market size is expected to reach USD 2.19 billion in 2024 and grow at a CAGR of 6.16% to reach USD 2.94 billion by 2029.

In 2024, the Europe CT Market size is expected to reach USD 2.19 billion.

Europe CT Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)